Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAMITA L BRYANT

Allopathic & Osteopathic Physicians Pain Medicine Pain Medicine

NPI
1669563920
CMS profile
120602
Location
NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$6,388.19

149 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 149 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAMITA L BRYANT

NPI 1669563920 · CMS profile ID 120602

Allopathic & Osteopathic Physicians / Pain Medicine / Pain Medicine

NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 149 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1669563920?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAMITA L BRYANT, NPI 1669563920, CMS profile ID 120602. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 149 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1669563920?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). DAMITA L BRYANT, NPI 1669563920, CMS profile ID 120602. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 149 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1669563920?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
DAMITA L BRYANT, NPI 1669563920, CMS profile ID 120602, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 149 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1669563920?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

149 matching records · $6,388.19 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 149 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 149.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Biohaven Pharmaceuticals, Inc. $8.7308/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852441389 CMS
Amgen Inc. $20.2708/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825238181 CMS
Currax Pharmaceuticals LLC $5.6008/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792526551 CMS
AbbVie Inc. $1.6408/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794175007 CMS
Lilly USA, LLC $23.7508/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819030819 CMS
UPSHER-SMITH LABORATORIES LLC $22.8108/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834694651 CMS
Supernus Pharmaceuticals, Inc. $13.0308/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845013305 CMS
Biohaven Pharmaceuticals, Inc. $23.0108/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852441385 CMS
AbbVie Inc. $17.8208/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794175003 CMS
AbbVie Inc. $4.9408/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794174999 CMS
UPSHER-SMITH LABORATORIES LLC $15.7308/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834693527 CMS
Lilly USA, LLC $11.7708/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818903001 CMS
Lundbeck LLC $4.0608/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845900469 CMS
Allergan, Inc. $25.0307/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792719341 CMS
Currax Pharmaceuticals LLC $14.8807/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792526549 CMS
Amgen Inc. $15.7407/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825238173 CMS
AbbVie Inc. $15.2107/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794174995 CMS
Amgen Inc. $42.2607/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825238177 CMS
Lundbeck LLC $72.6307/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845900467 CMS
UPSHER-SMITH LABORATORIES LLC $21.0207/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834692185 CMS
Supernus Pharmaceuticals, Inc. $17.1507/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845013301 CMS
Biohaven Pharmaceuticals, Inc. $5.5407/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852441381 CMS
AbbVie Inc. $5.0507/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794174991 CMS
Supernus Pharmaceuticals, Inc. $21.1006/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845013297 CMS
AbbVie Inc. $4.1406/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794174987 CMS
UPSHER-SMITH LABORATORIES LLC $12.2106/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834691275 CMS
Biohaven Pharmaceuticals, Inc. $18.6306/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852441377 CMS
Amgen Inc. $15.7606/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825238165 CMS
Biohaven Pharmaceuticals, Inc. $5.1606/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852441373 CMS
Lilly USA, LLC $16.2806/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819026923 CMS
Lundbeck LLC $12.7906/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845900465 CMS
AbbVie Inc. $4.0006/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794174983 CMS
UPSHER-SMITH LABORATORIES LLC $13.9106/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834686097 CMS
Supernus Pharmaceuticals, Inc. $23.2506/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845013293 CMS
Biohaven Pharmaceuticals, Inc. $151.0106/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852441369 CMS
AbbVie Inc. $1.7306/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794174979 CMS
Biohaven Pharmaceuticals, Inc. $7.6706/03/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852441365 CMS
Lundbeck LLC $5.7406/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845900463 CMS
AbbVie Inc. $4.8206/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794174975 CMS
Amgen Inc. $14.7005/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825238161 CMS
Supernus Pharmaceuticals, Inc. $22.9305/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845013291 CMS
Biohaven Pharmaceuticals, Inc. $7.0605/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852441359 CMS
Biohaven Pharmaceuticals, Inc. $1.0905/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852441363 CMS
AbbVie Inc. $6.5205/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794174971 CMS
Amgen Inc. $120.9605/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825238169 CMS
AbbVie Inc. $4.8705/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794174967 CMS
Lilly USA, LLC $15.6305/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819041125 CMS
Allergan, Inc. $19.6505/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792719339 CMS
UPSHER-SMITH LABORATORIES LLC $6.1905/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834680885 CMS
Biohaven Pharmaceuticals, Inc. $21.1805/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852441351 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,357.99 203
PY2020 $2,443.32 166
PY2021 $6,388.19 149
PY2022 $3,703.78 128
PY2023 $2,263.46 105
PY2024 $342.04 14

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $84,625.67 16
PY2023 Principal investigator $151,774.69 45
PY2022 Principal investigator $63,948.44 82
PY2021 Principal investigator $33,200.56 42
PY2020 Principal investigator $100,956.64 6
PY2019 Principal investigator $52,579.77 8

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

16 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,545.00 12/31/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
M22-418 Atogepant-Botox Combination Study No dispute reported 06/30/2026 1100766281
Principal investigator 1 ABBVIE INC. $2,000.00 08/01/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1100733222
Principal investigator 1 ABBVIE INC. $5,780.00 07/03/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine No dispute reported 06/30/2026 1100726212
Principal investigator 1 ABBVIE INC. $2,443.44 07/03/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1100726218
Principal investigator 1 ABBVIE INC. $1,780.00 06/05/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine No dispute reported 06/30/2026 1100721726
Principal investigator 1 ABBVIE INC. $1,221.72 06/05/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1100721728
Principal investigator 1 ABBVIE INC. $6,493.16 05/08/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1100716912
Principal investigator 1 ABBVIE INC. $3,370.00 04/04/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine No dispute reported 06/30/2026 1100712808
Principal investigator 1 ABBVIE INC. $6,048.88 04/04/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1100712916
Principal investigator 1 ABBVIE INC. $7,935.27 03/07/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1100706952
Principal investigator 1 ABBVIE INC. $6,795.00 03/07/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine No dispute reported 06/30/2026 1100707050
Principal investigator 1 ABBVIE INC. $4,801.77 02/01/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1100702232
Principal investigator 1 ABBVIE INC. $2,135.00 02/01/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine No dispute reported 06/30/2026 1100702234
Principal investigator 1 ABBVIE INC. $7,540.00 01/10/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine No dispute reported 06/30/2026 1100699589
Principal investigator 1 ABBVIE INC. $8,161.43 01/04/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1100698469
Principal investigator 1 ABBVIE INC. $16,575.00 01/04/2024 Non-covered Recipient Entity
BRYANT RESEARCH GROUP
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine No dispute reported 06/30/2026 1100698471